Skip to main content
Top

18-12-2023 | Antibiotic | Original Article

Procalcitonin Guided Antibiotic Stewardship in Pediatric Sepsis and Lower Respiratory Tract Infections

Authors: Adyasha Kanungo, Swathi Rao, Sumanth Shetty Bellipady, Sukanya Shetty

Published in: Indian Journal of Pediatrics

Login to get access

Abstract

Objectives

To determine the impact of procalcitonin-guided antibiotic stewardship protocol (PCT-ASP) in children admitted with sepsis and lower respiratory tract infection on the duration of antibiotic therapy and clinical outcome.

Methods

This was a single-center study involving children with infections treated with antibiotic therapy according to the PCT-ASP as the study group. The control group consisted of children with same age and diagnosis who were treated with antibiotics according to individual unit protocol before the implementation of PCT-ASP. The primary outcome was median duration of antibiotic therapy and hospital stay.

Results

Among 127 patients, 66 were enrolled in the study and 61 in the control group respectively. The median (IQR) PCT values at admission, day 4 and day 6 of antibiotic therapy were 5.59 (61.3), 2.57 (47.35), and 0.35 (0.47) ng/ml respectively, and showed a decreasing trend. All the children in the control group received antibiotics at admission while 12% of children in the study group were not initiated on antibiotics. In the study group, 53% of the children received antibiotics only for three days in the absence of treatment failure. The duration of antibiotics (p = 0.001) and hospital stay (p = 0.03) were less in the study group when compared to the control group.

Conclusions

PCT-ASP reduces the duration of antibiotics and duration of hospital stay without increasing morbidity and mortality.
Literature
1.
go back to reference Fioretto JR, Martin JG, Kurokawa CS, et al. Interleukin-6 and procalcitonin in children with sepsis and septic shock. Cytokine. 2008;43:160–4.CrossRefPubMed Fioretto JR, Martin JG, Kurokawa CS, et al. Interleukin-6 and procalcitonin in children with sepsis and septic shock. Cytokine. 2008;43:160–4.CrossRefPubMed
2.
go back to reference Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.CrossRef Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.CrossRef
3.
go back to reference Adorka M, Honoré MK, Lubbe M, Serfontein J, Allen K. The impact of appropriate antibiotic prescribing on treatment evaluation parameters. J Public Health Africa. 2013;4:e2.CrossRefPubMedCentral Adorka M, Honoré MK, Lubbe M, Serfontein J, Allen K. The impact of appropriate antibiotic prescribing on treatment evaluation parameters. J Public Health Africa. 2013;4:e2.CrossRefPubMedCentral
4.
go back to reference Branche A, Neeser O, Mueller B, Schuetz P. Procalcitonin to guide antibiotic decision making. Curr Opin Infect Dis. 2019;32:130–5.CrossRefPubMed Branche A, Neeser O, Mueller B, Schuetz P. Procalcitonin to guide antibiotic decision making. Curr Opin Infect Dis. 2019;32:130–5.CrossRefPubMed
5.
go back to reference Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international expert consensus on optimized clinical use. Clin Chem Lab Med. 2019;57:1308–18.CrossRefPubMed Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international expert consensus on optimized clinical use. Clin Chem Lab Med. 2019;57:1308–18.CrossRefPubMed
6.
go back to reference Lanziotti VS, Póvoa P, Soares M, Silva JR, Barbosa AP, Salluh JI. Use of biomarkers in pediatric sepsis: literature review. Rev Bras Ter Intensiva. 2016;28:472–82.CrossRefPubMedPubMedCentral Lanziotti VS, Póvoa P, Soares M, Silva JR, Barbosa AP, Salluh JI. Use of biomarkers in pediatric sepsis: literature review. Rev Bras Ter Intensiva. 2016;28:472–82.CrossRefPubMedPubMedCentral
7.
go back to reference Covington EW, Eure S, Carroll D, Freeman C. Impact of procalcitonin monitoring on duration of antibiotics in patients with sepsis and/or pneumonia in a community hospital setting. J Pharm Technol. 2018;34:109–16.CrossRefPubMedPubMedCentral Covington EW, Eure S, Carroll D, Freeman C. Impact of procalcitonin monitoring on duration of antibiotics in patients with sepsis and/or pneumonia in a community hospital setting. J Pharm Technol. 2018;34:109–16.CrossRefPubMedPubMedCentral
8.
go back to reference de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819–27.CrossRefPubMed de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819–27.CrossRefPubMed
9.
go back to reference Kotula JJ 3rd, Moore WS 2nd, Chopra A, Cies JJ. Association of procalcitonin value and bacterial coinfections in pediatric patients with viral lower respiratory tract infections admitted to the pediatric intensive care unit. J Pediatr Pharmacol Ther. 2018;23:466–72. Kotula JJ 3rd, Moore WS 2nd, Chopra A, Cies JJ. Association of procalcitonin value and bacterial coinfections in pediatric patients with viral lower respiratory tract infections admitted to the pediatric intensive care unit. J Pediatr Pharmacol Ther. 2018;23:466–72.
10.
go back to reference Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375:463–74.CrossRefPubMed Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375:463–74.CrossRefPubMed
11.
go back to reference Albrich WC, Dusemund F, Bucher B, et al; ProREAL study team. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life”: an international, multicenter post study survey (ProREAL). Arch Intern Med. 2012;172:715–22. Albrich WC, Dusemund F, Bucher B, et al; ProREAL study team. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life”: an international, multicenter post study survey (ProREAL). Arch Intern Med. 2012;172:715–22.
12.
go back to reference Wu G, Wu G, Wu S, Wu H. Comparison of procalcitonin guidance-administered antibiotics with standard guidelines on antibiotic therapy in children with lower respiratory tract infections: a retrospective study in China. Med Princ Pract. 2017;26:316–20.CrossRefPubMedPubMedCentral Wu G, Wu G, Wu S, Wu H. Comparison of procalcitonin guidance-administered antibiotics with standard guidelines on antibiotic therapy in children with lower respiratory tract infections: a retrospective study in China. Med Princ Pract. 2017;26:316–20.CrossRefPubMedPubMedCentral
13.
go back to reference Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst. Rev. 2017;10:CD007498. Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst. Rev. 2017;10:CD007498.
14.
go back to reference Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2007;177:498–505.CrossRefPubMed Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2007;177:498–505.CrossRefPubMed
15.
go back to reference Bishop BM, Bon JJ, Trienski TL, Pasquale TR, Martin BR, File TM Jr. Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit. Ann Pharmacother. 2014;48:577–83.CrossRefPubMed Bishop BM, Bon JJ, Trienski TL, Pasquale TR, Martin BR, File TM Jr. Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit. Ann Pharmacother. 2014;48:577–83.CrossRefPubMed
16.
go back to reference Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18:95–107.CrossRefPubMed Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18:95–107.CrossRefPubMed
17.
go back to reference Magrini L, Gagliano G, Travaglino F, et al. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department. Clin Chem Lab Med. 2014;52:1465–72.CrossRefPubMed Magrini L, Gagliano G, Travaglino F, et al. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department. Clin Chem Lab Med. 2014;52:1465–72.CrossRefPubMed
18.
go back to reference Çil E, Karadeniz G, Yenigün S, Çoraplı G. Evaluation of the relationships between procalcitonin and neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with pneumonia. Eur Rev Med Pharmacol Sci. 2022;26:3200–5.PubMed Çil E, Karadeniz G, Yenigün S, Çoraplı G. Evaluation of the relationships between procalcitonin and neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with pneumonia. Eur Rev Med Pharmacol Sci. 2022;26:3200–5.PubMed
Metadata
Title
Procalcitonin Guided Antibiotic Stewardship in Pediatric Sepsis and Lower Respiratory Tract Infections
Authors
Adyasha Kanungo
Swathi Rao
Sumanth Shetty Bellipady
Sukanya Shetty
Publication date
18-12-2023
Publisher
Springer India
Published in
Indian Journal of Pediatrics
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-023-04960-8